Yoh Asahi
Overview
Explore the profile of Yoh Asahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wakizaka K, Shichi S, Aiyama T, Asahi Y, Nagatsu A, Orimo T, et al.
Ann Surg Open
. 2024 Dec;
5(4):e523.
PMID: 39711678
Objective: This study investigated the risk factors and management of portal vein thrombosis (PVT) after hepatectomy. Background: PVT after hepatectomy can cause liver dysfunction and portal hypertension, and may be...
2.
Asahi Y, Xu C, Okuno K, Taketomi A, Goel A
Phytomedicine
. 2024 Sep;
135:156086.
PMID: 39326133
Background: Aronia berry extracts (ABE) have recently been reported to possess significant anti-cancer effects in various malignancies, including colorectal cancer (CRC), due to their high polyphenolic content. However, the molecular...
3.
Asahi Y, Kakisaka T, Kamiyama T, Orimo T, Shimada S, Nagatsu A, et al.
Hepatol Res
. 2024 Jul;
PMID: 39058650
Aim: This study was undertaken to evaluate the outcome of curative liver resection, (LR) of Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma (BCLC-C HCC) after tyrosine kinase inhibitors (TKIs)...
4.
Shichi S, Sugiyama K, Asahi Y, Shirakawa C, Nakamoto H, Kimura S, et al.
Cancer Med
. 2024 May;
13(9):e7238.
PMID: 38716625
Background: Intrahepatic cholangiocarcinoma (ICC) has a high recurrence rate and a poor prognosis. Thus, the development of effective treatment and prognostic biomarkers is required. High expression of diacylglycerol kinase alpha...
5.
Shiu P, Ilieva M, Holm A, Uchida S, DiStefano J, Bronisz A, et al.
Noncoding RNA
. 2023 Apr;
9(2).
PMID: 37104010
We are delighted to share with you our twelfth Journal Club and highlight some of the most interesting papers published recently [...].
6.
Tsuzaka S, Aiyama T, Kamachi H, Kakisaka T, Orimo T, Nagatsu A, et al.
Microsurgery
. 2023 Apr;
43(6):606-610.
PMID: 37016794
Chylous ascites, the leakage of lymphatic fluid into the abdominal cavity caused by lymphatic fluid stasis or lymphatic vessel damage, can be treated by lymphaticovenous anastomosis (LVA). We report rarely...
7.
Sano S, Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, et al.
Int Cancer Conf J
. 2023 Jan;
12(1):7-13.
PMID: 36605836
Although systemic treatment for hepatocellular carcinoma has advanced after the development of tyrosine kinase inhibitors such as sorafenib and lenvatinib, the effectiveness of a single tyrosine kinase inhibitor in survival...
8.
Sakamoto Y, Shimada S, Kamiyama T, Sugiyama K, Asahi Y, Nagatsu A, et al.
World J Gastrointest Surg
. 2022 Sep;
14(7):670-684.
PMID: 36158275
Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. However, the number of patients with chronic kidney disease (CKD) is on the rise because of the increase...
9.
Orimo T, Kamiyama T, Kakisaka T, Nagatsu A, Asahi Y, Aiyama T, et al.
Ann Surg Oncol
. 2022 Sep;
29(13):8436-8445.
PMID: 36100832
Background: A single hepatocellular carcinoma (HCC) is a good indication for hepatic resection regardless of tumor size, but the surgical indications for cases with multiple HCCs remain unclear. Methods: We...
10.
Ohashi K, Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, et al.
Int Cancer Conf J
. 2022 Jun;
11(3):178-183.
PMID: 35669906
This is an additional case report of a malignant triton tumor arising in the duodenum that was removed by pancreatoduodenectomy. Liver and gallbladder dysfunctions were detected in a regular blood...